APA (7th ed.) Citation

C, T., S, C., A, D. S., E, Q., G, L., G, C., . . . G, C. (2007). Analysis of severe hepatic events associated with nevirapine-containing regimens: CD4+ T-cell count and gender in hepatitis C seropositive and seronegative patients. Drug safety, 30(12), 1161. https://doi.org/10.2165/00002018-200730120-00008

Chicago Style (17th ed.) Citation

C, Torti, et al. "Analysis of Severe Hepatic Events Associated with Nevirapine-containing Regimens: CD4+ T-cell Count and Gender in Hepatitis C Seropositive and Seronegative Patients." Drug Safety 30, no. 12 (2007): 1161. https://doi.org/10.2165/00002018-200730120-00008.

MLA (9th ed.) Citation

C, Torti, et al. "Analysis of Severe Hepatic Events Associated with Nevirapine-containing Regimens: CD4+ T-cell Count and Gender in Hepatitis C Seropositive and Seronegative Patients." Drug Safety, vol. 30, no. 12, 2007, p. 1161, https://doi.org/10.2165/00002018-200730120-00008.